Article
Translational Potential and Pharmacokinetic Challenges of Procyanidin C1 as a Next-Generation Senotherapeutic Agent
2026-02-19
Abstract excerpt
Procyanidin C1 (PCC1), a B-type procyanidin trimer derived from natural sources, has recently garnered significant attention in preclinical models due to its potential to specifically induce apoptosis in senescent cells (senolytic activity) and extend healthspan. However, existing data reveal a pronounced pharmacological paradox: the in vitro induction of apoptosis in senescent cells typically requires high microm...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- de1ffd2c-a6e7-5c49-ab21-2f8ae6a982a5
- DOI
- 10.20944/preprints202602.1086.v1
